Capsaicin enhances the antitumor activity of sorafenib in hepatocellular carcinoma cells and mouse xenograft tumors through increased ERK signaling

Sorafenib, a small inhibitor of tyrosine protein kinases, is currently the standard chemotherapy drug for the treatment of advanced hepatocellular carcinoma (HCC). Although sorafenib improves the survival of HCC patients, its efficacy is not optimal and requires further improvement. Capsaicin, the m...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Acta Pharmacol Sin
Main Authors: Zhang, Su-shan, Ni, Yu-hao, Zhao, Chen-ru, Qiao, Zhen, Yu, Hong-xia, Wang, Lu-yao, Sun, Jin-yan, Du, Chen, Zhang, Jia-hao, Dong, Li-ying, Wang, KeWei, Gao, Jian-jun
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2018
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5843835/
https://ncbi.nlm.nih.gov/pubmed/29188798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/aps.2017.156
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares